1. Home
  2. /
  3. ORTHOPEDICS
  4. /
  5. BIOVISC ORTHO SINGLE
Home / ORTHOPEDICS / BIOVISC ORTHO SINGLE

BIOVISC ORTHO SINGLE

PREMIUM SINGLE INJECTION VISCOSUPPLEMENT

BIOVISC ORTHO SINGLE is a cross-linked, non-surgical, non-pharmacologic therapy for Knee Osteoarthritis, a disease of joints characterized by progressive degradation of the cartilage and bone deformation. BIOVISC ORTHO SINGLE is a treatment for patients who suffer from Osteoarthritis showing symptoms like knee pain, stiffness, articulator limited mobility, crack, swelling, functional impairment, and even deformations.

BIOVISC ORTHO SINGLE is a highly viscous gel formulated with high molecular weight (2.8 to 3.2 Mio Dalton) injectable grade hyaluronic acid from the bio-fermentation origin, HA gel indicated for use as an intra-articular injection in the patients suffering from Osteoarthritis of knee joint.

eIFU Publication

How BIOVISC ORTHO SINGLE Works?

BIOVISC ORTHO is the exogenous source of Hyaluronic Acid that restores the Synovial fluid balance in OA condition. The administration of BIOVISC ORTHO increases the viscosity of the Synovial fluid, restoring its lubricating, shock-absorbing and filtering properties. Furthermore, it re-establishes the protective HA coating over the inner surface of the joint and increases the scavenging of free radicals.

As a result, inflammation of the Synovium is reduced. This relieves pain and increases mobility of the joint.

Features

Single injection viscosupplement

Pain relief and improved mobility for up to 12 months

Technical Specifications

HA Content3% (90mg)
PHBetween 6.8 to 7.6

Molecular Weight
2.8 to 3.2 million dalton

Pack1 × 3 ml PFS

Indications

For knee joint

SUPPLY

BIOVISC SINGLE is supplied sterile and non-pyrogenic in Latex-free pre-filled syringes with 3 ml fill volumes.

DOWNLOAD PRODUCT BROCHURE

ADDITIONAL PRODUCT

BIOVISC SINGLE is available with 60 mg/2ml for special orders in this segment.

Battig Treuhand AG
Obergrundstrasse 17,
6002, Luzern,
Switzerland

CATEGORIES
CONTACT US
Biotech Health Care